BridgeMD
New treatment option for Cardiovascular Risk
Official title Impact of the Corrie Lipids Digital Health Program on Lipid Optimization
ClinicalTrials.gov ID: NCT07478887
What this study is testing
- What it's testing
- The overall objective is to evaluate the effectiveness and implementation of the Corrie Lipids Program, a comprehensive digital health initiative designed to address critical gaps in lipid-lowering as a component of ASCVD treatment by delivering an intervention that combines a patient-facing smartphone app, clinician education and coaching, and seamless incorporation into clinical workflows. Researchers plan to assess this multicenter digital health initiative in approximately 1,000 adults with uncontrolled LDL-C and elevated ASCVD risk using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years
- Uncontrolled LDL-C per AHA/ACC guidelines
- At least 1 major cardiovascular risk factor, including: high risk for ASCVD (individuals who meet criteria for Lipid-Lowering Therapy (LLT) based on...
- Has a primary care physician and/or cardiologist who can prescribe lipid therapy
- Owns a smartphone and agrees to the End User License Agreement to use the digital health app
You likely can't join if
- Motor, cognitive, auditory, or visual impairment limiting technology use
- Does not speak English
- Malignancy (except nonmelanoma skin cancers or cervical or breast ductal carcinoma in situ within the previous 5 years)
- Pregnancy (positive pregnancy test, highly sensitive urine or serum), plan to become pregnant or donate eggs, breastfeeding or plan to breastfeed
- Likely to not be available to comply with all required study procedures to the best of the patient's and investigator's knowledge
- History or evidence of any other clinically significant disorder, condition, or disease that, in the opinion of the investigator, would pose a risk...
See the full eligibility criteria
- Age ≥18 years
- Uncontrolled LDL-C per AHA/ACC guidelines
- At least 1 major cardiovascular risk factor, including: high risk for ASCVD (individuals who meet criteria for Lipid-Lowering Therapy (LLT) based on ASCVD risk assessment using the most up-to-date guidelines), known...
- Has a primary care physician and/or cardiologist who can prescribe lipid therapy
- Owns a smartphone and agrees to the End User License Agreement to use the digital health app
- Provided informed consent before initiation of study-specific activities
- Motor, cognitive, auditory, or visual impairment limiting technology use
- Does not speak English
- Malignancy (except nonmelanoma skin cancers or cervical or breast ductal carcinoma in situ within the previous 5 years)
- Pregnancy (positive pregnancy test, highly sensitive urine or serum), plan to become pregnant or donate eggs, breastfeeding or plan to breastfeed
- Likely to not be available to comply with all required study procedures to the best of the patient's and investigator's knowledge
- History or evidence of any other clinically significant disorder, condition, or disease that, in the opinion of the investigator, would pose a risk to patient safety or interfere with the study evaluation, procedures...
The study team makes the final eligibility decision.
Where it's taking place
- Baltimore, Maryland, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baltimore, Maryland, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.